ATS 2020 Advance Program

CLINICAL • TRANSLATIONAL YEAR IN REVIEW B81 PEDIATRIC YEAR IN REVIEW Assembly on Pediatrics 2:15 p.m. - 4:15 p.m. Target Audience Providers of lung health for children, clinical researchers who study pediatric lung health problems Objectives At the conclusion of this session, the participant will be able to: • learn new findings about scientific developments in the field of bronchopulmonary disease that have clinical relevance; • learn new clinical practices being to minimize lung injury and that optimize long-term outcome in children with bronchopulmonary dysplasia; • learn new imaging modalities and biomarkers being use to help predict outcomes in children with bronchopulmonary dysplasia. This session will provide up to date and state of the art information on the treatment of childhood asthma, pediatric neuromuscular diseases that effect lung health, chronic lung disease that effects preterm infants and the impact of e-cigarettes on respiratory health of children. Chairing: S.A. McGrath-Morrow, MD, Baltimore, MD P.D. Robinson, MD, PhD, Sydney, Australia 2:15 Update on the Management of Bronchopulmonary Dysplasia P.E. Moore, MD, ATSF, Nashville, TN 2:45 Childhood Health Consequences of Electronic Cigarettes E.R. Neptune, MD, Baltimore, MD 3:15 What’s New in Therapies for Neuromuscular Lung Diseases O.H. Mayer, MD, Philadelphia, PA 3:45 Update on New Treatments for Asthma L. Fleming, MD, MBChB, London, United Kingdom CLINICAL CLINICAL TOPICS IN PULMONARY MEDICINE B82 ROLE OF SURGERY FOR PLEURAL DISEASES IN 2020: WHAT PULMONOLOGISTS NEED TO KNOW Assemblies on Clinical Problems; Thoracic Oncology 2:15 p.m. - 4:15 p.m. Target Audience Clinicians, nurses, allied health staff and researchers in respiratory diseases: chest physicians, interventional pulmonologists, thoracic/general surgeons, oncologists, general/emergency physicians, junior staff and scientists. Objectives At the conclusion of this session, the participant will be able to: • learn about advances in thoracic surgical techniques in the diagnosis and treatment of pleural effusions and pneumothorax; • understand latest clinical trial evidence on best management of malignant effusions; • gain knowledge on the latest research finding on imaging guided pleural biopsy and new molecular markers for mesothelioma. Thoracic surgery is conventionally used in the work-up and treatment of pleural diseases. Recent research advances in malignant effusion, empyema and pneumothorax offer less invasive options to surgery and transform care via high-profile trials eg on malignant effusions (IPC-PLUS [NEJM2018]; AMPLE-1 [JAMA2017] and AMPLE-2 [Lancet Respir Med2018]; on mesothelioma, (SMART [Lancet Oncol2017]; MAPPs and Meso-VATS [Lancet]) and on pleural infection. Advances in imaging-guided biopsy and molecular diagnosis further reduce the need of diagnostic surgical investigations. The session will inform pulmonologists on practical application of these ATS 2020 • Philadelphia, PA MONDAY • MAY 18 87